Application 021433

Type: NDA
Sponsor: GLAXO GRP LTD

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	FLOVENT HFA	FLUTICASONE PROPIONATE	AEROSOL, METERED;INHALATION	0.22MG/INH	Yes	Yes
002	FLOVENT HFA	FLUTICASONE PROPIONATE	AEROSOL, METERED;INHALATION	0.11MG/INH	Yes	Yes
003	FLOVENT HFA	FLUTICASONE PROPIONATE	AEROSOL, METERED;INHALATION	0.044MG/INH	Yes	Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021433-001	FLOVENT HFA	FLUTICASONE PROPIONATE	0.22MG/INH	AEROSOL, METERED / INHALATION		RLD, RS	2004-05-14
N021433-002	FLOVENT HFA	FLUTICASONE PROPIONATE	0.11MG/INH	AEROSOL, METERED / INHALATION		RLD, RS	2004-05-14
N021433-003	FLOVENT HFA	FLUTICASONE PROPIONATE	0.044MG/INH	AEROSOL, METERED / INHALATION	AB	RLD, RS	2004-05-14

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
N021433-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021433-001	FLOVENT HFA	0.22MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021433-002	FLOVENT HFA	0.11MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021433-003	FLOVENT HFA	0.044MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021433-001	FLOVENT HFA	0.22MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021433-002	FLOVENT HFA	0.11MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021433-003	FLOVENT HFA	0.044MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021433-001	FLOVENT HFA	0.22MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021433-002	FLOVENT HFA	0.11MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021433-003	FLOVENT HFA	0.044MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021433-001	FLOVENT HFA	0.22MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021433-002	FLOVENT HFA	0.11MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021433-003	FLOVENT HFA	0.044MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021433-001	FLOVENT HFA	0.22MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021433-002	FLOVENT HFA	0.11MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021433-003	FLOVENT HFA	0.044MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021433-001	FLOVENT HFA	0.22MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021433-002	FLOVENT HFA	0.11MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021433-003	FLOVENT HFA	0.044MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021433-001	FLOVENT HFA	0.22MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021433-002	FLOVENT HFA	0.11MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021433-003	FLOVENT HFA	0.044MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021433-001	FLOVENT HFA	0.22MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021433-002	FLOVENT HFA	0.11MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021433-003	FLOVENT HFA	0.044MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021433-001	FLOVENT HFA	0.22MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021433-002	FLOVENT HFA	0.11MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021433-003	FLOVENT HFA	0.044MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021433-001	FLOVENT HFA	0.22MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021433-002	FLOVENT HFA	0.11MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021433-003	FLOVENT HFA	0.044MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021433-001	FLOVENT HFA	0.22MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021433-002	FLOVENT HFA	0.11MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021433-003	FLOVENT HFA	0.044MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021433-001	FLOVENT HFA	0.22MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021433-002	FLOVENT HFA	0.11MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021433-003	FLOVENT HFA	0.044MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021433-001	FLOVENT HFA	0.22MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021433-002	FLOVENT HFA	0.11MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021433-003	FLOVENT HFA	0.044MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021433-001	FLOVENT HFA	0.22MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-05-14	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N021433-003	AB	1	`a50c72e98297…`

Observed Orange Book patent history#

Patent history page 1 of 10 · 400 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Coverage / status	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021433-001	7500444	2026-02-26	Drug product, Delist requested	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021433-001	7500444*PED	2026-08-26	Pediatric extension	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021433-002	7500444	2026-02-26	Drug product, Delist requested	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021433-002	7500444*PED	2026-08-26	Pediatric extension	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021433-001	7500444	2026-02-26	Drug product, Delist requested	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021433-001	7500444*PED	2026-08-26	Pediatric extension	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021433-002	7500444	2026-02-26	Drug product, Delist requested	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021433-002	7500444*PED	2026-08-26	Pediatric extension	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021433-001	7500444	2026-02-26	Drug product, Delist requested	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021433-001	7500444*PED	2026-08-26	Pediatric extension	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021433-002	7500444	2026-02-26	Drug product, Delist requested	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021433-002	7500444*PED	2026-08-26	Pediatric extension	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021433-001	7500444	2026-02-26	Drug product, Delist requested	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021433-001	7500444*PED	2026-08-26	Pediatric extension	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021433-002	7500444	2026-02-26	Drug product, Delist requested	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021433-002	7500444*PED	2026-08-26	Pediatric extension	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021433-001	7500444	2026-02-26	Drug product, Delist requested	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021433-001	7500444*PED	2026-08-26	Pediatric extension	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021433-002	7500444	2026-02-26	Drug product, Delist requested	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021433-002	7500444*PED	2026-08-26	Pediatric extension	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021433-001	7500444	2026-02-26	Drug product, Delist requested	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021433-001	7500444*PED	2026-08-26	Pediatric extension	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021433-002	7500444	2026-02-26	Drug product, Delist requested	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021433-002	7500444*PED	2026-08-26	Pediatric extension	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021433-001	7500444	2026-02-26	Drug product, Delist requested	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021433-001	7500444*PED	2026-08-26	Pediatric extension	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021433-002	7500444	2026-02-26	Drug product, Delist requested	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021433-002	7500444*PED	2026-08-26	Pediatric extension	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021433-001	7500444	2026-02-26	Drug product, Delist requested	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021433-001	7500444*PED	2026-08-26	Pediatric extension	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021433-002	7500444	2026-02-26	Drug product, Delist requested	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021433-002	7500444*PED	2026-08-26	Pediatric extension	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021433-001	7500444	2026-02-26	Drug product, Delist requested	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021433-001	7500444*PED	2026-08-26	Pediatric extension	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021433-002	7500444	2026-02-26	Drug product, Delist requested	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021433-002	7500444*PED	2026-08-26	Pediatric extension	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021433-001	7500444	2026-02-26	Drug product, Delist requested	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021433-001	7500444*PED	2026-08-26	Pediatric extension	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021433-002	7500444	2026-02-26	Drug product, Delist requested	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021433-002	7500444*PED	2026-08-26	Pediatric extension	`d06236e962d9…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Fluticasone Propionate HFA	FLUTICASONE PROPIONATE	Preferred Pharmaceuticals Inc.	ff1cf174-ae6f-45f0-a081-26a34e55f9ea	2026-01-20	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021433 application number: NDA021433
Fluticasone Propionate HFA	FLUTICASONE PROPIONATE	A-S Medication Solutions	faaa1436-dafb-4f65-b062-b51b902f43c5	2024-10-29	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021433 application number: NDA021433 ndc (product): 50090-6055
Fluticasone Propionate HFA	FLUTICASONE PROPIONATE	A-S Medication Solutions	674b1c81-359d-4fc4-8ce6-a53931b171e0	2024-01-02	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021433 application number: NDA021433 ndc (product): 50090-6053
FLOVENT HFA	FLUTICASONE PROPIONATE	A-S Medication Solutions	74563f7b-8512-4b76-8c55-b88b9cd3206b	2023-12-09	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021433 application number: NDA021433 ndc (product): 50090-0934
Fluticasone Propionate HFA	FLUTICASONE PROPIONATE	A-S Medication Solutions	4d3e6801-5fbf-4cf6-b3d8-35fe276b8b6d	2023-11-17	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021433 application number: NDA021433 ndc (product): 50090-6058
Fluticasone Propionate HFA	FLUTICASONE PROPIONATE	Prasco Laboratories	99249b31-bf0a-464f-8335-845279350dbe	2023-09-28	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021433 application number: NDA021433 ndc (product): 66993-079 ndc (product): 66993-078 ndc (product): 66993-080

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 49 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
0173-0718	FLOVENT	fluticasone propionate	GlaxoSmithKline LLC	NDA	Current
0173-0718	FLOVENT	fluticasone propionate	GlaxoSmithKline LLC	NDA	Current
0173-0718	FLOVENT	fluticasone propionate	GlaxoSmithKline LLC	NDA	Current
0173-0718	FLOVENT	fluticasone propionate	GlaxoSmithKline LLC	NDA	Current
0173-0718	FLOVENT	fluticasone propionate	GlaxoSmithKline LLC	NDA	Current
0173-0718	FLOVENT	fluticasone propionate	GlaxoSmithKline LLC	NDA	Current
0173-0718	FLOVENT	fluticasone propionate	GlaxoSmithKline LLC	NDA	Current
0173-0718	FLOVENT	fluticasone propionate	GlaxoSmithKline LLC	NDA	Current
0173-0719	FLOVENT	fluticasone propionate	GlaxoSmithKline LLC	NDA	Current
0173-0719	FLOVENT	fluticasone propionate	GlaxoSmithKline LLC	NDA	Current
0173-0719	FLOVENT	fluticasone propionate	GlaxoSmithKline LLC	NDA	Current
0173-0719	FLOVENT	fluticasone propionate	GlaxoSmithKline LLC	NDA	Current
0173-0719	FLOVENT	fluticasone propionate	GlaxoSmithKline LLC	NDA	Current
0173-0719	FLOVENT	fluticasone propionate	GlaxoSmithKline LLC	NDA	Current
0173-0719	FLOVENT	fluticasone propionate	GlaxoSmithKline LLC	NDA	Current
0173-0719	FLOVENT	fluticasone propionate	GlaxoSmithKline LLC	NDA	Current
0173-0720	FLOVENT	fluticasone propionate	GlaxoSmithKline LLC	NDA	Current
0173-0720	FLOVENT	fluticasone propionate	GlaxoSmithKline LLC	NDA	Current
0173-0720	FLOVENT	fluticasone propionate	GlaxoSmithKline LLC	NDA	Current
0173-0720	FLOVENT	fluticasone propionate	GlaxoSmithKline LLC	NDA	Current
0173-0720	FLOVENT	fluticasone propionate	GlaxoSmithKline LLC	NDA	Current
0173-0720	FLOVENT	fluticasone propionate	GlaxoSmithKline LLC	NDA	Current
0173-0720	FLOVENT	fluticasone propionate	GlaxoSmithKline LLC	NDA	Current
0173-0720	FLOVENT	fluticasone propionate	GlaxoSmithKline LLC	NDA	Current
50090-0910	FLOVENT	fluticasone propionate	A-S Medication Solutions	NDA	Current
50090-0910	FLOVENT	fluticasone propionate	A-S Medication Solutions	NDA	Current
50090-0910	FLOVENT	fluticasone propionate	A-S Medication Solutions	NDA	Current
50090-0916	FLOVENT	fluticasone propionate	A-S Medication Solutions	NDA	Current
50090-0916	FLOVENT	fluticasone propionate	A-S Medication Solutions	NDA	Current
50090-0916	FLOVENT	fluticasone propionate	A-S Medication Solutions	NDA	Current
50090-0934	FLOVENT	fluticasone propionate	A-S Medication Solutions	NDA	Current
50090-0934	FLOVENT	fluticasone propionate	A-S Medication Solutions	NDA	Current
50090-0934	FLOVENT	fluticasone propionate	A-S Medication Solutions	NDA	Current
50090-0934	FLOVENT	fluticasone propionate	A-S Medication Solutions	NDA	Current
50090-6053	Fluticasone Propionate	fluticasone propionate	A-S Medication Solutions	NDA AUTHORIZED GENERIC	Current
50090-6055	Fluticasone Propionate	fluticasone propionate	A-S Medication Solutions	NDA AUTHORIZED GENERIC	Current
50090-6058	Fluticasone Propionate	fluticasone propionate	A-S Medication Solutions	NDA AUTHORIZED GENERIC	Current
53002-1294	FLOVENT	fluticasone propionate	RPK Pharmaceuticals, Inc.	NDA	Current
53002-1310	FLOVENT	fluticasone propionate	RPK Pharmaceuticals, Inc.	NDA	Current
53002-1310	FLOVENT	fluticasone propionate	RPK Pharmaceuticals, Inc.	NDA	Current
66993-078	Fluticasone Propionate	fluticasone propionate	Prasco Laboratories	NDA AUTHORIZED GENERIC	Current
66993-079	Fluticasone Propionate	fluticasone propionate	Prasco Laboratories	NDA AUTHORIZED GENERIC	Current
66993-080	Fluticasone Propionate	fluticasone propionate	Prasco Laboratories	NDA AUTHORIZED GENERIC	Current
68788-6926	FLOVENT	fluticasone propionate	Preferred Pharmaceuticals Inc.	NDA	Current
68788-6926	FLOVENT	fluticasone propionate	Preferred Pharmaceuticals Inc.	NDA	Current
68788-6926	FLOVENT	fluticasone propionate	Preferred Pharmaceuticals Inc.	NDA	Current
68788-6926	FLOVENT	fluticasone propionate	Preferred Pharmaceuticals Inc.	NDA	Current
68788-6926	FLOVENT	fluticasone propionate	Preferred Pharmaceuticals Inc.	NDA	Current
70518-0310	FLOVENT	fluticasone propionate	REMEDYREPACK INC.	NDA	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
68419	SUPPL	2021-08-19
68409	SUPPL	2021-08-19
57519	SUPPL	2019-02-13
57130	SUPPL	2019-01-08
49039	SUPPL	2017-07-21
49027	SUPPL	2017-07-20
45593	SUPPL	2016-10-07
45508	SUPPL	2016-10-06
15451	SUPPL	2016-08-02
5357	SUPPL	2016-08-01
27759	SUPPL	2014-12-12
36911	SUPPL	2014-12-11
5355	SUPPL	2014-12-03
15450	SUPPL	2014-11-20
5356	SUPPL	2014-11-17
36910	SUPPL	2013-07-23
27758	SUPPL	2013-07-22
36909	SUPPL	2011-08-05
5354	SUPPL	2010-11-08
36908	SUPPL	2010-11-03
36907	SUPPL	2008-07-09
5353	SUPPL	2008-07-02
5352	SUPPL	2006-10-27
36906	SUPPL	2006-10-26
36905	SUPPL	2006-03-03
27756	SUPPL	2006-03-03
27757	SUPPL	2006-01-18
15449	SUPPL	2006-01-05
21651	ORIG	2005-12-06
36904	ORIG	2004-05-27
27755	ORIG	2004-05-26
63520	ORIG	1900-01-01